Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension.
about
Association of Matrix Metalloproteinase-9 Gene -1562C/T Polymorphism with Essential Hypertension: A Systematic Review and Meta-Analysis ArticleA critical role for proinflammatory behavior of smooth muscle cells in hemodynamic initiation of intracranial aneurysmStudy of the correlations among some parameters of the oxidative status, gelatinases, and their inhibitors in a group of subjects with metabolic syndrome.Bortezomib, a proteasome inhibitor, attenuates angiotensin II-induced hypertension and aortic remodeling in rats.Dexamethasone Suppressed LPS-Induced Matrix Metalloproteinase and Its Effect on Endothelial Glycocalyx Shedding.Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertensionMatrix metalloproteinases as drug targets in preeclampsiaBiotic acts of antibioticsAn emerging role of degrading proteinases in hypertension and the metabolic syndrome: autodigestion and receptor cleavage.Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension.The effect of inositol hexaphosphate on the expression of selected metalloproteinases and their tissue inhibitors in IL-1β-stimulated colon cancer cells.Captopril and lisinopril only inhibit matrix metalloproteinase-2 (MMP-2) activity at millimolar concentrations.Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR.Doxycycline speeds up healing of chronic venous ulcers.Matrix metalloproteinases: a target in in-stent restenosis?.Behaviour of the plasma concentration of gelatinases and their tissue inhibitors in subjects with venous leg ulcers.Kalpaamruthaa ameliorates myocardial and aortic damage in cardiovascular complications associated with type 2 diabetes mellitus.Electrical and histological remodeling of the pulmonary vein in 2K1C hypertensive rats: Indication of initiation and maintenance of atrial fibrillation.
P2860
Q26770159-7A8888EA-0F7E-40CC-BAD0-A8B36A69C9C1Q28536539-4E40C3AA-86BB-42F1-9B59-C8B42CB4A5E9Q33999929-11C5FF94-BCB7-4E8D-8DFF-2DD078248542Q35036537-6EF91D87-AB25-40BE-807B-C909169CAF35Q35823888-C4894183-9135-449B-ACD1-057AA5FF8A77Q36042695-2926160F-CF19-45C0-89A6-9A534AE5F676Q36910638-14D6B856-3D71-4362-9C91-ED5F3A9FBCCCQ37101851-2FC5A8DE-1B2B-44D0-AC96-07AF4BE3C6CBQ37955866-E63D426D-929F-4DB5-B2FB-CB2597609D85Q39255610-3908DC2C-9392-45B2-9003-32D8B0FF473AQ39380237-68516406-7768-4EB8-A6F6-F49E3804F76FQ41230502-B5697FFB-9297-4009-B154-D82E56D7BF3CQ43538572-64C22592-1BCB-4268-AAE0-EF4734F06FF2Q43642111-B0044211-CC2B-4208-828C-1FB22FA3F272Q44513191-EF325CEF-D645-4EBE-B277-90AD0557DCF0Q44842992-4641BBE9-F0C1-44E3-B398-E71C0D850C61Q45110311-F9C21445-5FE2-49F0-89FC-D81624F9C52EQ50019267-6555233B-60EF-40D7-9ACD-7D8C73893FD4
P2860
Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Matrix metalloproteinases: tar ...... r alterations of hypertension.
@en
Matrix metalloproteinases: tar ...... r alterations of hypertension.
@nl
type
label
Matrix metalloproteinases: tar ...... r alterations of hypertension.
@en
Matrix metalloproteinases: tar ...... r alterations of hypertension.
@nl
prefLabel
Matrix metalloproteinases: tar ...... r alterations of hypertension.
@en
Matrix metalloproteinases: tar ...... r alterations of hypertension.
@nl
P2093
P1476
Matrix metalloproteinases: tar ...... r alterations of hypertension.
@en
P2093
Jose E Tanus-Santos
Michele M Castro
Raquel F Gerlach
P304
P356
10.1016/J.PHRS.2011.04.002
P577
2011-04-09T00:00:00Z